247 related articles for article (PubMed ID: 25983054)
21. Suboptimal response to adefovir dipivoxil therapy for chronic hepatitis B in nucleoside-naive patients is not due to pre-existing drug-resistant mutants.
Carrouée-Durantel S; Durantel D; Werle-Lapostolle B; Pichoud C; Naesens L; Neyts J; Trépo C; Zoulim F
Antivir Ther; 2008; 13(3):381-8. PubMed ID: 18572751
[TBL] [Abstract][Full Text] [Related]
22. [The predictive value of ALT, HBeAg and HBV DNA levels at baseline and the degree of HBV suppression at week 12 adefovir dipivoxil treatment to the efficacy of it at week 52 in patients with HBeAg-positive chronic hepatitis B].
Xie DY; Lin BL; Xu QH; Chen YM; Lu WL; Li JG; Gao ZL
Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):341-4. PubMed ID: 18510844
[TBL] [Abstract][Full Text] [Related]
23. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.
Marcellin P; Heathcote EJ; Buti M; Gane E; de Man RA; Krastev Z; Germanidis G; Lee SS; Flisiak R; Kaita K; Manns M; Kotzev I; Tchernev K; Buggisch P; Weilert F; Kurdas OO; Shiffman ML; Trinh H; Washington MK; Sorbel J; Anderson J; Snow-Lampart A; Mondou E; Quinn J; Rousseau F
N Engl J Med; 2008 Dec; 359(23):2442-55. PubMed ID: 19052126
[TBL] [Abstract][Full Text] [Related]
24. Changes in viral loads of lamivudine-resistant mutants and evolution of HBV sequences during adefovir dipivoxil therapy.
Suzuki F; Kumada H; Nakamura H
J Med Virol; 2006 Aug; 78(8):1025-34. PubMed ID: 16789011
[TBL] [Abstract][Full Text] [Related]
25. A double-blind randomized trial of adefovir dipivoxil in Chinese subjects with HBeAg-positive chronic hepatitis B.
Zeng M; Mao Y; Yao G; Wang H; Hou J; Wang Y; Ji BN; Chang CN; Barker KF
Hepatology; 2006 Jul; 44(1):108-16. PubMed ID: 16799983
[TBL] [Abstract][Full Text] [Related]
26. [Efficacy of adefovir dipivoxil was not related to genotypes B and C of hepatitis B virus: a randomized, double-blind, multicenter clinical study].
Zhao H; Li J; Zhang YX; Chen XY; Wang L; Tang XP; Lei CL; Si CW
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):282-4. PubMed ID: 17971947
[TBL] [Abstract][Full Text] [Related]
27. Combination of Lamivudine and adefovir therapy in HBeAg-positive chronic hepatitis B patients with poor response to adefovir monotherapy.
Wang LC; Chen EQ; Cao J; Liu L; Wang JR; Lei BJ; Tang H
J Viral Hepat; 2010 Mar; 17(3):178-84. PubMed ID: 19656287
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of adefovir dipivoxil in the treatment of lamivudine-resistant hepatitis B virus genotype C infection.
Kim DY; Kim HJ; Lee CK; Suh JH; Kim DH; Cho YS; Won SY; Park BK; Park IS
Liver Int; 2007 Feb; 27(1):47-53. PubMed ID: 17241380
[TBL] [Abstract][Full Text] [Related]
29. Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy.
van Bömmel F; Zöllner B; Sarrazin C; Spengler U; Hüppe D; Möller B; Feucht HH; Wiedenmann B; Berg T
Hepatology; 2006 Aug; 44(2):318-25. PubMed ID: 16871563
[TBL] [Abstract][Full Text] [Related]
30. [Entecavir 1.0mg monotherapy or entecavir plus adefovir dipivoxil for patients with lamivudine-resistant chronic hepatitis B had suboptimal response to lamivudine plus adefovir dipivoxil].
Xing J; Han T; Liu L; Li Y; Li J; Li Y; Xiao SX
Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):828-32. PubMed ID: 22433304
[TBL] [Abstract][Full Text] [Related]
31. Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B.
Lau GK; Cooksley H; Ribeiro RM; Powers KA; Shudo E; Bowden S; Hui CK; Anderson J; Sorbel J; Mondou E; Rousseau F; Lewin S; Perelson AS; Locornini S; Naoumov NV
Antivir Ther; 2007; 12(5):705-18. PubMed ID: 17713154
[TBL] [Abstract][Full Text] [Related]
32. [A clinical study of adefovir dipivoxil in treating lamivudine refractory HBeAg-positive chronic hepatitis B].
Zhao H; Zhang YX; Chen XY; Wang L; Tang XP; Si CW
Zhonghua Nei Ke Za Zhi; 2007 Apr; 46(4):294-7. PubMed ID: 17637268
[TBL] [Abstract][Full Text] [Related]
33. Tenofovir rescue regimen following prior suboptimal response to entecavir and adefovir combination therapy in chronic hepatitis B patients exposed to multiple treatment failures.
Zhang Q; Han T; Nie CY; Ha FS; Liu L; Liu H
J Med Virol; 2015 Jun; 87(6):1013-21. PubMed ID: 25716029
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of tenofovir in adefovir-experienced patients compared with treatment-naive patients with chronic hepatitis B.
Keskin O; Ormeci AC; Baran B; Kabaçam G; Tüzün A; Karatayli E; Akyüz F; Karatayli S; Bozdayi AM; Onel D; Badur S; Idilman R; Kaymakoglu S; Yurdaydin C
Antivir Ther; 2014; 19(6):543-50. PubMed ID: 24517926
[TBL] [Abstract][Full Text] [Related]
35. Pooled analysis of amino acid changes in the HBV polymerase in patients from four major adefovir dipivoxil clinical trials.
Borroto-Esoda K; Miller MD; Arterburn S
J Hepatol; 2007 Oct; 47(4):492-8. PubMed ID: 17692425
[TBL] [Abstract][Full Text] [Related]
36. Evolution of hepatitis B viral load and viral genome sequence during adefovir dipivoxil therapy.
Werle B; Cinquin K; Marcellin P; Pol S; Maynard M; Trépo C; Zoulim F
J Viral Hepat; 2004 Jan; 11(1):74-83. PubMed ID: 14738561
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of antiviral responses to adefovir dipivoxil therapy of genotype B and genotype C HBV infected patients].
Zeng AZ; Deng H; Peng FY; Xin XJ; Yang C; Li QL; Guo JJ; Zhang ZZ; Hao MJ; Yuan Z; Huang WX; Huang AL
Zhonghua Gan Zang Bing Za Zhi; 2008 Jun; 16(6):412-5. PubMed ID: 18578989
[TBL] [Abstract][Full Text] [Related]
38. Serum levels of surface large envelope proteins: prognostic markers for hepatitis B e antigen-negative patients with adefovir dipivoxil treatment.
Fan X; Fang D; Bin D; Xueyong L; Jun C; Hongshan W
Antivir Ther; 2009; 14(8):1149-56. PubMed ID: 20032544
[TBL] [Abstract][Full Text] [Related]
39. Clinical course and predictive factors of virological response in long-term lamivudine plus adefovir dipivoxil combination therapy for lamivudine-resistant chronic hepatitis B patients.
Aizawa M; Tsubota A; Fujise K; Tatsuzawa K; Kono M; Hoshina S; Tajiri H
J Med Virol; 2011 Jun; 83(6):953-61. PubMed ID: 21503906
[TBL] [Abstract][Full Text] [Related]
40. Lamivudine plus adefovir or entecavir for patients with chronic hepatitis B resistant to lamivudine and adefovir.
Heo NY; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
J Hepatol; 2010 Sep; 53(3):449-54. PubMed ID: 20646776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
